vs
COLUMBIA BANKING SYSTEM, INC.（COLB）与Royalty Pharma plc（RPRX）财务数据对比。点击上方公司名可切换其他公司
COLUMBIA BANKING SYSTEM, INC.的季度营收约是Royalty Pharma plc的1.2倍（$716.7M vs $622.0M），Royalty Pharma plc净利率更高（34.4% vs 30.0%，领先4.4%），COLUMBIA BANKING SYSTEM, INC.同比增速更快（47.1% vs 4.8%），过去两年COLUMBIA BANKING SYSTEM, INC.的营收复合增速更高（23.0% vs 4.6%）
昂普夸控股公司（运营品牌为昂普夸银行）是总部位于美国俄勒冈州波特兰市中心的金融控股企业，总部设在昂普夸银行广场，该处原为本杰明·富兰克林储蓄贷款协会总部，旗下拥有昂普夸银行、昂普夸投资两大核心运营子公司。
本公司是总部位于美国马萨诸塞州剑桥市的临床阶段生物制药企业，专注于研发可调节转化生长因子β（TGF-β）超家族蛋白的药物，该类蛋白在红细胞、肌肉、骨骼、血管等细胞与组织的生长修复过程中发挥核心作用。
COLB vs RPRX — 直观对比
营收规模更大
COLB
是对方的1.2倍
$622.0M
营收增速更快
COLB
高出42.4%
4.8%
净利率更高
RPRX
高出4.4%
30.0%
两年增速更快
COLB
近两年复合增速
4.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $716.7M | $622.0M |
| 净利润 | $215.0M | $214.2M |
| 毛利率 | — | — |
| 营业利润率 | — | 62.4% |
| 净利率 | 30.0% | 34.4% |
| 营收同比 | 47.1% | 4.8% |
| 净利润同比 | 50.3% | 2.9% |
| 每股收益（稀释后） | $0.76 | $0.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收COLBRPRX
| Q4 25 | $716.7M | $622.0M | ||
| Q3 25 | $582.0M | $609.3M | ||
| Q2 25 | $510.9M | $578.7M | ||
| Q1 25 | $491.4M | $568.2M | ||
| Q4 24 | $487.1M | $593.6M | ||
| Q3 24 | $496.0M | $564.7M | ||
| Q2 24 | $472.2M | $537.3M | ||
| Q1 24 | $473.7M | $568.0M |
净利润COLBRPRX
| Q4 25 | $215.0M | $214.2M | ||
| Q3 25 | $96.0M | $288.2M | ||
| Q2 25 | $152.0M | $30.2M | ||
| Q1 25 | $87.0M | $238.3M | ||
| Q4 24 | $143.0M | $208.2M | ||
| Q3 24 | $146.0M | $544.0M | ||
| Q2 24 | $121.0M | $102.0M | ||
| Q1 24 | $124.0M | $4.8M |
营业利润率COLBRPRX
| Q4 25 | — | 62.4% | ||
| Q3 25 | — | 70.1% | ||
| Q2 25 | — | 36.3% | ||
| Q1 25 | — | 94.0% | ||
| Q4 24 | — | 60.9% | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 50.2% | ||
| Q1 24 | — | -13.0% |
净利率COLBRPRX
| Q4 25 | 30.0% | 34.4% | ||
| Q3 25 | 16.5% | 47.3% | ||
| Q2 25 | 29.8% | 5.2% | ||
| Q1 25 | 17.7% | 41.9% | ||
| Q4 24 | 29.4% | 35.1% | ||
| Q3 24 | 29.4% | 96.3% | ||
| Q2 24 | 25.6% | 19.0% | ||
| Q1 24 | 26.2% | 0.8% |
每股收益（稀释后）COLBRPRX
| Q4 25 | $0.76 | $0.49 | ||
| Q3 25 | $0.40 | $0.67 | ||
| Q2 25 | $0.73 | $0.07 | ||
| Q1 25 | $0.41 | $0.55 | ||
| Q4 24 | $0.69 | $0.46 | ||
| Q3 24 | $0.70 | $1.21 | ||
| Q2 24 | $0.57 | $0.23 | ||
| Q1 24 | $0.59 | $0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $2.4B | $618.7M |
| 总债务越低越好 | — | $9.0B |
| 股东权益账面价值 | $7.8B | $9.7B |
| 总资产 | $66.8B | $19.6B |
| 负债/权益比越低杠杆越低 | — | 0.92× |
8季度趋势，按日历期对齐
现金及短期投资COLBRPRX
| Q4 25 | $2.4B | $618.7M | ||
| Q3 25 | $2.3B | $938.9M | ||
| Q2 25 | $1.9B | $631.9M | ||
| Q1 25 | $2.1B | $1.1B | ||
| Q4 24 | $1.9B | $929.0M | ||
| Q3 24 | $2.1B | $950.1M | ||
| Q2 24 | $2.1B | $1.8B | ||
| Q1 24 | $2.2B | $843.0M |
总债务COLBRPRX
| Q4 25 | — | $9.0B | ||
| Q3 25 | — | $8.9B | ||
| Q2 25 | — | $8.0B | ||
| Q1 25 | — | $7.6B | ||
| Q4 24 | — | $7.6B | ||
| Q3 24 | — | $7.6B | ||
| Q2 24 | — | $7.6B | ||
| Q1 24 | — | $6.1B |
股东权益COLBRPRX
| Q4 25 | $7.8B | $9.7B | ||
| Q3 25 | $7.8B | $9.6B | ||
| Q2 25 | $5.3B | $9.5B | ||
| Q1 25 | $5.2B | $9.8B | ||
| Q4 24 | $5.1B | $10.3B | ||
| Q3 24 | $5.3B | $10.3B | ||
| Q2 24 | $5.0B | $9.8B | ||
| Q1 24 | $5.0B | $9.9B |
总资产COLBRPRX
| Q4 25 | $66.8B | $19.6B | ||
| Q3 25 | $67.5B | $19.3B | ||
| Q2 25 | $51.9B | $18.3B | ||
| Q1 25 | $51.5B | $17.6B | ||
| Q4 24 | $51.6B | $18.2B | ||
| Q3 24 | $51.9B | $18.0B | ||
| Q2 24 | $52.0B | $17.7B | ||
| Q1 24 | $52.2B | $16.1B |
负债/权益比COLBRPRX
| Q4 25 | — | 0.92× | ||
| Q3 25 | — | 0.93× | ||
| Q2 25 | — | 0.84× | ||
| Q1 25 | — | 0.78× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 0.74× | ||
| Q2 24 | — | 0.78× | ||
| Q1 24 | — | 0.62× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $746.0M | $827.1M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | 3.47× | 3.86× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流COLBRPRX
| Q4 25 | $746.0M | $827.1M | ||
| Q3 25 | $236.2M | $702.6M | ||
| Q2 25 | $106.8M | $364.0M | ||
| Q1 25 | $122.0M | $596.1M | ||
| Q4 24 | $659.0M | $742.5M | ||
| Q3 24 | $67.2M | $703.6M | ||
| Q2 24 | $150.3M | $658.2M | ||
| Q1 24 | $185.5M | $664.6M |
现金转化率COLBRPRX
| Q4 25 | 3.47× | 3.86× | ||
| Q3 25 | 2.46× | 2.44× | ||
| Q2 25 | 0.70× | 12.06× | ||
| Q1 25 | 1.40× | 2.50× | ||
| Q4 24 | 4.61× | 3.57× | ||
| Q3 24 | 0.46× | 1.29× | ||
| Q2 24 | 1.24× | 6.45× | ||
| Q1 24 | 1.50× | 139.10× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
COLB
暂无分部数据
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
